These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17679350)

  • 1. Magnetic resonance imaging of the failing heart.
    Lauerma K
    Scand J Surg; 2007; 96(2):102-6. PubMed ID: 17679350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium enhancement imaging in assessment of myocardial viability: techniques and clinical applications.
    Jimenez Juan L; Crean AM; Wintersperger BJ
    Radiol Clin North Am; 2015 Mar; 53(2):397-411. PubMed ID: 25727002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CMR examination in heart failure.
    Raman SV; Simonetti OP
    Heart Fail Clin; 2009 Jul; 5(3):283-300, v. PubMed ID: 19564009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of myocardial viability with cardiac magnetic resonance imaging.
    Ozben B; Cinçin AA; Mutlu B
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ischemic heart disease using magnetic resonance first-pass perfusion imaging.
    Mühling O; Jerosch-Herold M; Näbauer M; Wilke N
    Herz; 2003 Mar; 28(2):82-9. PubMed ID: 12669221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cardiovascular magnetic resonance imaging in heart failure.
    Karamitsos TD; Francis JM; Myerson S; Selvanayagam JB; Neubauer S
    J Am Coll Cardiol; 2009 Oct; 54(15):1407-24. PubMed ID: 19796734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure.
    Prasad SK; Kotwinski P; Assomul R
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):53-9. PubMed ID: 15038413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging for the assessment of myocardial viability.
    Thomson LE; Kim RJ; Judd RM
    J Magn Reson Imaging; 2004 Jun; 19(6):771-88. PubMed ID: 15170783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance for the assessment of myocardial viability.
    Isbell DC; Kramer CM
    Curr Opin Cardiol; 2006 Sep; 21(5):469-72. PubMed ID: 16900010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure.
    Swoboda PP; Plein S
    Expert Rev Cardiovasc Ther; 2014 Jan; 12(1):45-55. PubMed ID: 24345093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viability by MRI or PET would not have changed the results of the STICH trial.
    Asrani NS; Chareonthaitawee P; Pellikka PA
    Prog Cardiovasc Dis; 2013; 55(5):494-7. PubMed ID: 23518378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability by MRI or PET would have changed the results of the STICH trial.
    Srichai MB; Jaber WA
    Prog Cardiovasc Dis; 2013; 55(5):487-93. PubMed ID: 23518377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis.
    Muzzarelli S; Ordovas K; Higgins CB
    J Magn Reson Imaging; 2011 Feb; 33(2):275-86. PubMed ID: 21274968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of septal myocardial infarction on outcomes after surgical ventricular restoration.
    Patel ND; Nwakanma LU; Weiss ES; Williams JA; Conte JV
    Ann Thorac Surg; 2008 Jan; 85(1):135-45; discussion 145-6. PubMed ID: 18154799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac dysfunction in heart failure with normal ejection fraction: MRI measurements.
    Rademakers FE; Bogaert J
    Prog Cardiovasc Dis; 2006; 49(3):215-27. PubMed ID: 17084181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The post-myocardial infarction scarred ventricle and congestive heart failure: the preeminence of magnetic resonance imaging for preoperative, intraoperative, and postoperative assessment.
    Dor V; Civaia F; Alexandrescu C; Montiglio F
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1405-12. PubMed ID: 19114182
    [No Abstract]   [Full Text] [Related]  

  • 18. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
    Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular magnetic resonance in the evaluation of heart failure: a luxury or a need?
    D'Andrea A; Fontana M; Cocchia R; Scarafile R; Calabrò R; Moon JC
    J Cardiovasc Med (Hagerstown); 2012 Jan; 13(1):24-31. PubMed ID: 22130042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial viability in patients with heart failure.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    J Nucl Med; 2007 Jul; 48(7):1135-46. PubMed ID: 17574986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.